Patents Assigned to Boston Life Sciences
  • Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1
    Publication number: 20060211614
    Abstract: The present invention relates to methods of inhibiting angiogenesis associated with a disease or disorder with peptides homologous to amino acid residues 130-137 or 132-139 of human troponin subunit I.
    Type: Application
    Filed: January 5, 2006
    Publication date: September 21, 2006
    Applicants: Boston Life Sciences, Children's Medical Center Corporation
    Inventors: Richard Thorn, Marc Lanser, Marsha Moses, Dmitri Wiederschain
  • Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
    Patent number: 7078385
    Abstract: The present invention relates to methods of inhibiting angiogenesis associated with a disease or disorder with peptides homologous to amino acid residues 130–137 or 132–139 of human troponin subunit I.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: July 18, 2006
    Assignees: Boston Life Sciences, Inc., Children's Medical Center Corporation
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
    Publication number: 20030186864
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of troponin C, I or T subunits, fragments or homologs for the treatment of diseases or disorders involving abnormal angiogenesis and methods of use thereof.
    Type: Application
    Filed: June 18, 2002
    Publication date: October 2, 2003
    Applicant: Boston Life Sciences, Inc.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Troponin subunit I fragment and homologs thereof
    Patent number: 6586401
    Abstract: The present invention relates to a peptide corresponding to human troponin subunit fragment I amino acid residues 118-137 and homologs thereof, as well as pharmaceutical compositions.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: July 1, 2003
    Assignees: Children's Medical Center Corporation, Boston Life Sciences, Inc.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Pharmaceutical compositions comprising fragments and homologs of troponin subunits
    Publication number: 20030083255
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of troponin C, I or T subunits, fragments or homologs for the treatment of diseases or disorders involving abnormal angiogenesis and methods of use thereof.
    Type: Application
    Filed: July 9, 2002
    Publication date: May 1, 2003
    Applicant: Boston Life Sciences, Inc.
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain
  • Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
    Patent number: 6465431
    Abstract: The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of troponin C, I or T subunits, fragments, or homologs thereof, for the treatment of diseases or disorders involving abnormal angiogenesis and methods of use thereof.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: October 15, 2002
    Assignees: Boston Life Sciences, Inc., Children's Medical Center Corporation
    Inventors: Richard M. Thorn, Marc E. Lanser, Marsha A. Moses, Dmitri G. Wiederschain